Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
BLRX
BioLineRx Ltd.
BioLineRx's lead oncology asset motixafortide (APHEXDA) places the company squarely in oncology with an approved stem cell mobilization therapy and ongoing cancer indications development.
|
$8.26M |
$3.44
-3.10%
|
|
TSBX
Turnstone Biologics Corp.
Company's core business is oncology-focused biotechnology, including immunotherapy approaches (TIL-based strategies) in solid tumors.
|
$8.21M |
$0.35
|
|
BGLC
BioNexus Gene Lab Corp.
VitaGuard MRD is a tumor-naïve liquid biopsy platform used in BGLC's MRNA Scientific diagnostics, defining a liquid biopsy product category.
|
$8.16M |
$4.42
+2.31%
|
|
PAVM
PAVmed Inc.
EsoGuard and EsoCheck are proprietary diagnostic devices/tests used for esophageal precancer detection, a direct diagnostic equipment product line.
|
$7.96M |
$0.37
+9.62%
|
|
KTTA
Pasithea Therapeutics Corp.
Pasithea's lead candidate PAS-4.00 is a MEK inhibitor targeting MAPK pathway-driven tumors, aligning with oncology-focused biotech.
|
$7.89M |
$0.95
+95.37%
|
|
EVGN
Evogene Ltd.
Biomica's microbiome therapeutics program (BMC128) targets human health, fitting Immunology Therapeutics within Biotech.
|
$7.71M |
$1.11
+1.36%
|
|
RNAZ
TransCode Therapeutics, Inc.
TransCode Therapeutics operates in biotech oncology, developing cancer therapeutics.
|
$7.69M |
$9.30
+1.25%
|
|
SCND
Scientific Industries, Inc.
Medical Devices & Biometrics – automated pharmacy hardware and other medical device equipment.
|
$7.63M |
$0.64
|
|
BIXT
Bioxytran, Inc.
MDX Viewer is an FDA-approved diagnostic device that measures tissue oxygenation and provides real-time metabolic insights; a direct product/service Bioxytran provides.
|
$7.56M |
$0.09
|
|
PRPH
ProPhase Labs, Inc.
BE-Smart diagnostic test and RUO/LDT commercialization imply laboratory testing and advisory services.
|
$7.52M |
$0.19
+3.45%
|
|
TRIB
Trinity Biotech plc
Directly manufactures glucose monitoring hardware (CGM) and wearable biosensors with an accompanying data platform.
|
$7.51M |
$0.96
+7.45%
|
|
APM
Aptorum Group Limited
Aptorum plans near-term revenue from biopharma services via the DiamiR merger, aligning with contract research/Development outsourcing.
|
$7.33M |
$1.33
+4.72%
|
|
LCTC
Lifeloc Technologies, Inc.
Lifeloc Technologies manufactures breath alcohol testing devices, which are diagnostic instruments used for disease detection and monitoring.
|
$7.31M |
$3.10
|
|
APRE
Aprea Therapeutics, Inc.
APRE is an oncology-focused biotech developing cancer therapies, namely DDR inhibitors, which aligns with Biotech - Oncology.
|
$7.28M |
$1.26
+4.13%
|
|
CLDI
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics directly develops cancer therapies (oncolytic virus platforms) targeting oncology indications.
|
$7.07M |
$1.49
+6.43%
|
|
PHIO
Phio Pharmaceuticals Corp.
INTASYL is based on RNA interference (siRNA), making RNAi therapeutics a core product/framework.
|
$7.04M |
$1.24
+3.33%
|
|
BCTX
BriaCell Therapeutics Corp.
BriaCell develops off-the-shelf allogeneic cell therapies (Bria-IMT) and a cell-therapy platform (Bria-OTS).
|
$6.97M |
$10.38
+7.56%
|
|
XAIR
Beyond Air, Inc.
LungFit is a medical device platform that generates nitric oxide and is sold/distributed to hospitals.
|
$6.95M |
$1.33
-0.37%
|
|
CELZ
Creative Medical Technology Holdings, Inc.
CELZ develops autologous/allogeneic cell therapies (ImmCelz and AlloStem), a core cell therapy business.
|
$6.89M |
$2.67
-2.55%
|
|
ADIL
Adial Pharmaceuticals, Inc.
Lead AUD program is a neuropsychiatric CNS therapeutic, aligning with Neuropsychiatric Drug Development.
|
$6.77M |
$0.31
+2.35%
|
|
DQWS
DSwiss, Inc.
DQWS provides turnkey OEM/ODM contract manufacturing services for health care, beauty, and nutraceutical products.
|
$6.62M |
$0.03
|
|
PHGE
BiomX Inc.
BiomX leverages a drug delivery platform (BOLT) to rapidly assemble phage cocktails and targeted therapies.
|
$6.56M |
$4.71
-18.60%
|
|
NVNO
enVVeno Medical Corporation
NVNO designs and manufactures medical devices, including implantable bioprosthetic venous valves and related biometrics/sensing technology.
|
$6.54M |
$0.34
-6.11%
|
|
BMRA
Biomerica, Inc.
Biomerica directly manufactures diagnostic tests (inFoods IBS, hpdetect) and related software/equipment.
|
$6.53M |
$2.33
-2.51%
|
|
ALZN
Alzamend Neuro, Inc.
Company's pipeline includes Alzheimer's disease therapeutics (ALZN002) and a focused strategy on Alzheimer's treatment.
|
$6.49M |
$2.25
+4.91%
|
Showing page 35 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
